Dr. Anwesha Dey is an Executive Director and Distinguished Scientist in the Discovery Oncology Department at Genentech.
Her scientific research is focused on understanding the biology of Hippo and PI3K signaling pathways and how they can be targeted for cancer therapy. She is also a Project Team Leader for a late stage research drug discovery program at Genentech where she leads a large interdisciplinary team focused on small molecule drug discovery. Prior to this position, she held postdoctoral research fellowships in the laboratory of Vishva Dixit at Genentech and at the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore in the laboratory of Sir David Lane. She did her PhD in the laboratory of Dr. Michael Summers at the Howard Hughes Medical Institute at UMBC, Maryland and received her undergraduate degree in Biotechnology from National University of Singapore.
In addition to scientific research and discovery, she is passionate about mentoring the next generation of scientists at Genentech and beyond. Outside of work, she loves spending time with her family and enjoying fun activities with her daughter.
Please join us on Thursday, October 10, 2024 from 2 pm - 3 pm in the TLC, UC 115, for an information session to hear about the opportunities at Genentech, Inc.
Please check this event post at the TLC myUMBC: https://my3.my.umbc.edu/groups/tlc/events/135095